| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 466,672,674 | 476,820,023 | -2.128 | 455,948,497 | 2.352 |
| Total Profit (Loss) | 184,116,950 | 191,500,836 | -3.855 | 173,303,330 | 6.239 |
| Profit (Loss) Operational | 46,541,610 | 44,361,333 | 4.914 | 33,425,506 | 39.239 |
| Net Profit (Loss) after Zakat and Tax | 8,907,048 | 25,530,269 | -65.111 | 7,732,608 | 15.188 |
| Total Comprehensive Income | 12,431,977 | 5,909,674 | 110.366 | -12,253,860 | - |
| All figures are in (Actual) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Share Holders Equity (after deducting minority equity) | 1,070,631,943 | 1,128,613,459 | -5.137 |
| Profit (Loss) per Share | 0.11 | 0.32 | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| Reason for increase (decrease) in net profit for current quarter compared to the same quarter of the previous year | Net profit decreases in general due to: |
A) Higher Financial charges mainly in Pharmaceuticals and Specialty chemicals sectors.
B) Lower other income mainly in Pharmaceuticals sector.
C) Lower gross profits in Pharmaceuticals and Power and Steel sectors.
D) Lower sales.
While noting that there was a decrease in G&A and S&M expenses.
Higher sales in following sectors:
1) Pharmaceuticals sector
2) Power and Steel sector
While noting that there was increase in financial charges
2. The company has adopted IFRS 16 for Leases from the initial application date of January 1st, 2019, with recognition of Right-of-use assets (SR51M), Lease liability (SR49M) and decrease in Prepayments (SR2M). Please refer to note 4 in the interim condensed consolidated financial statements.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.